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doi:10.1016/j.kjms.2011.06.028Abstract Recently, adult stem cells have been identified in several mature tissues. The
human endometrium is responsive to sex steroid hormone. It undergoes extraordinary growth
in a cyclic manner and is shed and regenerated throughout a woman’s lifetime. It has been
proposed that the human endometrium may contain a population of stem cells, which are
responsible for its remarkable regenerative ability. It is also suggested that stem-like cells
exist in cancer tissues. Stem-like cell subpopulations, referred to as “side population” (SP)
cells, have been identified in several tissues and tumors based on their ability to efflux the
fluorescent dye Hoechst 33342. Recently, we isolated and characterized the SP cells in normal
human endometrium and in an endometrial cancer (EC) cell line. Endometrial SP cells can
function as progenitor cells. EC SP cells show the following: (1) reductions in the expression
levels of differentiation markers; (2) long-term repopulating properties; (3) self-renewal
capacity; (4) enhancement of migration and podia formation; (5) enhancement of tumorige-
nicity; and (6) bipotent developmental potential (tumor cells and stroma-like cells), suggest-
ing that these SP cells have cancer stem-like cell features. We review the articles that show
the presence of stem cells in normal endometrium and EC cells and demonstrate the results of
our studies.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.cology, Faculty of Medicine,
yo-ku, Tokyo, 113-8421 Japan.
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Recently, adult stem cells have been identified in several
mature tissues, such as the adult intestine [1], skin [2],
muscle [3], blood [4], and the nervous system [5e7]. A stem
cell is an undifferentiated cell that is defined by its ability
to both self-renew and to produce mature progeny cells [8].ed.
64 K. KatoStem cells are classified based on their developmental
potential as being totipotent, pluripotent, oligopotent, and
unipotent. Adult somatic stem cells were originally thought
to be tissue specific and only able to give rise to progeny
cells corresponding to their tissue of origin. Recent studies,
however, have shown that adult mammalian stem cells are
able to differentiate across tissue lineage boundaries
[9,10], although this “plasticity” of adult somatic stem cells
remains controversial.
Stem cell subpopulations [“side population” (SP) cells]
have been identified in many mammals, including humans,
based on the ability of these cells to efflux the fluorescent
dye Hoechst 33342 (Molecular Probes, Eugene, OR, USA)
[11]. Recent evidence suggests that the SP phenotype is
associated with a high expression level of the adenosine
triphosphate (ATP)-binding cassette transporter protein
ABCG2/Bcrp1 [12]. Most recently, established malignant
cell lines, which have been maintained for many years in
culture, have also been shown to contain SP cells as a minor
subpopulation [13].
The human endometrium is a highly dynamic tissue
undergoing cycles of growth, differentiation, shedding, and
regeneration throughout the reproductive life of women.
Endometrial adult stem/progenitor cells are likely to be
responsible for endometrial regeneration [14]. Rare pop-
ulations of human endometrial epithelial and stromal
colony-forming cells [15] and SP cells have been identified
by us and others [16e20]. Tsuji et al. [17] demonstrated
that Breast cancer resistance protein (BRCP)/ABCG2,
known as a marker of SP cells, was strongly expressed in the
vascular endometrium . Several groups have shown that
endometrial SP cells have multilineage developmental
potential (Table 1) [18,20].
Although coexpression of CD146 and platelet-derived
growth factor b (PDGF b) isolates a population of mesen-
chymal stem-like cells from human endometrium [21], the
specific stem cell markers of endometrium remain unclear.
Recently, Gotte et al. [22] demonstrated that the adult stem
cell marker, Musashi-1, was coexpressed with Notch-1 in
a subpopulation of endometrial cells. Furthermore, they
showed that telomerase- and Musashi-1-expressing cells
were significantly increased in proliferative endometrium,
endometriosis, and endometrial carcinoma tissue, comparedTable 1with secretary endometrium, which suggested the concept
of a stem cell origin of endometriosis and endometrial
carcinoma.
Endometrial cancer stem-like cells
Recent evidence suggests that cancer stem-like cells exist
in several malignant tumors, such as leukemia [23,24],
breast cancer [25], and brain tumors [26], and that these
stem cells express surface markers similar to those
expressed by normal stem cells in each tissue [23,27].
Endometrial cancer (EC) is the most common gyneco-
logical malignancy in the industrialized world. Two
different clinicopathological types can be distinguished: (1)
estrogen-related ECs (Type I) developing in pre- and post-
menopausal women, endometroid type and low cellular
grade, frequently preceded by endometrial hyperplasia and
with good prognosis. In Type I EC, estrogen receptor (ER,
especially ERa) was expressed. (2) Non-estrogen-related
ECs (Type II) occurring in postmenopausal women, non-
endometrioid type (mainly papillary serous or clear cell
carcinomas), without associated hyperplasia. Type II ECs
are negative for ER and progesterone receptor (PR), have
high cellular grade, and have a poor prognosis. The most
frequent genetic alteration in Type I EC is phosphatase and
tensin homolog (PTEN) inactivation, followed by micro-
satellite instability and mutations of the K-ras and b-cat-
enin. In Type II EC, p53 mutation is the most frequent
genetic alteration, followed by amplification of human
epidermal receptor 2 (HER2) (Table 2). Some of these
pathways are important determinants of stem cell activity
(Wnt-b-catenin and PTEN) [28e30]. These suggest that
there is a stem cell contribution to EC development.
Recently, Friel et al. [31] showed that SP cells were
derived from two EC cell lines (AN3CA and Ishikawa).
AN3CA had features of cancer stem-like cells, including
low proliferative activity during 9 days of cultivation,
chemoresistance, and enhanced tumorigenicity. Hubbard
et al. [32] demonstrated that a small population of clo-
nogenic cells from EC tissues showed self-renewing,
differentiating, and tumorigenic properties. Gotte et al.
[33] recently demonstrated that siRNA depletion of
Musashi-1, an adult stem cell marker enriched in SP cells,
in the endometrial carcinoma cell line Ishikawa leads to
interference with the notch signaling pathway and p21
expression, resulting in an antiproliferative effect and
induction of apoptosis.Table 2 Two clinicopathological types.
Type I Type II














Figure 1. CD9 and CD13 are surface markers in the normal human endometrium. The expressions of CD9 (A), CD13 (B), E-cad-
herin (C), and vimentin (D) in the human endometrium in the secretory phase were analyzed by immunohistochemistry using
formalin-fixed histological sections. HE staining of normal human endometrium in the secretory phase. The brown color in the panel
of CD9, CD13, E-cadherin, and vimentin shows the expression of each protein by immunohistochemistry using diaminobenzine
tetrahydrochloride as the substrate (magnification: 200, scale barZ 20 mm).
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SP cells
We have isolated SP cells from normal human endometrium
and characterized their properties [16]. CD9 is an epithelial
glandular marker and CD13 is a stromal marker in the normal
human endometrium (Fig. 1). We analyzed 34 samples of
the normal human endometrium. SP cells are present in
the human endometrium (mean, 0.27%) (Fig. 2A). For theFigure 2. Side population (SP) cells were present in the human e
33342 and analyzed by FACS. SP cells, which show a high level of
(meanZ 0.27%, nZ 34). Verapamil treatment increased the staini
the cell-surface markers of SP cells, cells stained with Hoechst 333
CD9 antibody and PE-conjugated anti-CD13 antibody. Most SP ce
population; SPZ side population.analysis of the surface marker of SP cells, endometrial cells
were stained with Hoechst 33342, followed by incubation
with fluorescein isothiocyanate (FITC)-conjugated CD9
antibody and phycoerythrin (PE)-conjugated CD13 antibody.
SP cells are enriched in negative fraction of both surface
markers (Fig. 2B).
Morphologically, SP cells are small and round (Fig. 3). We
followed a single SP cell for 48 hours. Daughter cells were-
generated from a single SP cell. We observed the long-termndometrium. (A) Endometrial cells were stained with Hoechst
dye efflux activity, were present in the human endometrium
ng and made SP cells undetectable by FACS. (B) For analysis of
42 dye were followed by incubation with FITC-conjugated anti-
lls were present in the CD9CD13 fraction. NSPZ noneside
Figure 3. Side population (SP) cells differentiated into gland-like cells. (A) Morphologically, the SP cells were small and round.
(B, C) SP cells after 1month of culture ona collagenplatewere cultured on feeder cells (aorta-gonad-mesonephrons (AGM) cells), which
were mitotically inactivated with 100 ng/mL mitomycin C (B: 3 months, magnification: 200, C: 5 months, magnification: 100).
(D) Cells forming a glandular-like structure on the collagen-coated plate were re-seeded in matrigel. (E, F) A piece of the matrigel was
fixed with 4% paraformaldehyde, embedded in paraffin and stained with hematoxylin and eosin. An endometrial gland-like structure
was observed (E: magnification: 200 scale barZ 20mm, F: magnification: 500 scale barZ 10mm).
66 K. Katoproliferative capacity of SP and non-SP (NSP) cells. NSP cells
showed limited proliferation and finally became senescent
within 3 months. In contrast, SP cells were successfully
maintained for 9 months, finally differentiated into gland-
like cells and constructed a gland-like structure (Fig. 3).
These results demonstrate that isolated SP cells in the
human endometrium have a long-proliferating potential and
produce gland-like cells. They can function as progenitor
cells.
After our publication, several groups have also reported
the existence and characteristics of SP cells in endome-
trium. It has been shown that endometrial SP cells have
a multilineage developmental potential [17e20].Characterization of EC SP cells
Recent evidence suggests that cancer stem cells exist in
several malignant tumors. We isolated and characterized SP
cells from human EC cells [34].Figure 4. Isolation of Side population (SP) cells from human end
metrial cancer cells (A and B) and Hec1 cells (C and D) (0.20% 0.
0.63 0.55% in Hec1 cells from 10 independent experiments). Verap
rendered the SP cells undetectable by FACS. NSPZ noneside popuWe first analyzed primary EC cells freshly isolated from
EC tissues after 7 days of cultivation (nZ 7) and a human
EC cell line, Hec1, by fluorescence-activated cell sorter
(FACS). SP cells were present in both cells. Verapamil
blocked the dye efflux (Fig. 4).
Next, both Hec1-SP and Hec1-NSP cells were cultured for
2 weeks, stained with Hoechst 33342, and then reanalyzed
by FACS. Hec1-SP cell cultures generated both SP and NSP
subpopulations. In contrast, NSP cell cultures produced NSP
cells but never SP cells. We demonstrated that SP cells from
human endometrium are negative for both CD9 and CD13.
This was also the case in the EC cell lines. The expression
levels of both CD9 and CD13 were lower in SP cells than
those in NSP cells.
SP and NSP cells derived from Hec1 cells were cultured
in mesenchymal stem cell maintenance medium (MF
medium). Cell growth rate was analyzed for 2 months. Both
cell types grew after 2 weeks of culture. SP cells continued
to grow for 2 months and accumulated in colonies atop the
confluent cell layer. In contrast, NSP cells stopped growing,ometrial cancer cells. SP cells were present in primary endo-
09% in primary endometrial cancer cells from seven cases and
amil treatment blocked the dye efflux, increased staining, and
lation; SP Z Side population.
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became flat and enlarged after 2 months. These results
show that SP cells, but not NSP cells, maintain a long-term
proliferating capacity of the cell culture (Fig. 5A). Next, we
analyzed self-renewal capacity by colony-forming potential
in serial cloning.
When Hec1-SP cells were plated in 24-well collagen-
coated dishes (50 cells/cm2), they proliferated and formed
colonies. Hec1-NSP cells were more loosely arranged and
did not form well-separated individual colonies. We disso-
ciated the primary colonies into single cells and then
cultured these cells. A single cell formed a secondary
colony. The secondary colonies generate tertiary colonies.
This indicates that the colony-forming cells isolated from
existing colonies retain the same colony-forming potential.
These results demonstrated that SP cells have a self-
renewal capability. NSP cells also produced secondary
clones, but there was much overlap. They did not form
well-separated individual colonies (Fig. 5B).
Cellular activity was monitored with time-lapse video
imaging studies. Interestingly, SP cells showed lamellipodia
formation at the leading edge and uropodia formation at
the trailing edge (Fig. 6). SP cells showed prominent
migration. NSP cells did not show podia formation and
migration (data not shown).Figure 5. Side population (SP) cells demonstrated the capacity fo
population cells derived from Hec1 cells were cultured on collagen
(MF medium) for 2 months. Cell growth rate was analyzed for 2 mon
in colonies on top of the confluent cell layer. In contrast, NSP cells
Data of cell numbers are represented as the mean  standard err
cloning plates were stained with crystal violet solution. The second
cells, formed well-separated colonies (scale barZ 10 mm). An aver
single cells (2.6%), and an average of 390 tertiary colonies were form
(1.9%). We counted the number of colonies in triplicate. Error bar
colonies in three independent experiments. (The number of col
7.43 3.09; the secondary colonies: 518 60.4; the tertiary colo
NSPZ noneside population; SPZ side population.Hec1-SP or Hec1-NSP cells were inoculated into the
subcutaneous tissues of nude mice. Tumors generated from
the SP cells grew faster and larger than those from the NSP
cells (Fig. 7A). The tumors were excised after 12 weeks of
inoculation. Hematoxylin-eosin staining showed that the SP
tumors were composed of tumor cells, surrounded by
stroma-like tissues with a markedly enriched extracellular
matrix (ECM). In contrast, most NSP tumors were composed
of well-encapsulated tumor cells that were not accompa-
nied by the ECM-enriched stroma.
The ECM is thought to be secreted by stromal cells.
Therefore, we analyzed the expression of specific mesen-
chymal cellular markers, vimentin and a-smooth muscle
actin (a-SMA), and collagen III as components of ECM. All
vimentin, a-SMA, and collagen III stained more strongly in
the SP tumors than in the NSP tumors (Fig. 7B).
The fact that the vimentin monoclonal antibody (V9)
used in this study reacted with human and rat vimentin, but
not with mouse vimentin, suggested the possibility that
vimentin-positive, stromal-like tissues in the tumors origi-
nated from the inoculated SP cells of Hec1 cells.
To confirm the origin of the stroma-like cells in the
Hec1-SP tumors, we also performed fluorescence in situ
hybridization assay on these two areas of Hec1-SP tumor
tissues using the spectrum orange-labeled CEP X (a satellite)r long-term proliferation and self-renewal. (A) SP and noneside
-coated plates in mesenchymal stem cell maintenance medium
ths. SP cells overgrew, lost contact inhibition, and accumulated
stopped growing after 2 weeks and became flat and enlarged.
or of the mean from three independent experiments. (B) The
ary cloning plates are shown. Hec1-SP cells, but not Hec1-NSP
age of 520 secondary colonies were formed per 2 104 seeded
ed per 2 104 seeded single cells from the secondary colonies
s represented standard error of the mean from the number of
onies per 2 104 seeded single cellsdthe primary colonies:
nies: 393 60.7.) *NSP> SP, pZ 0.02; **SP> NSP, pZ 0.0018.
Figure 6. Hec1-SP cells showed podia formation and prominent migration. In time-lapse video imaging studies, the frequency of
cell division was higher in Hec1-SP cells (A) than that in Hec1-NSP cells (B). Hec1-SP cells showed podia formation (lamellipodia at
the leading edge, shown by arrow, and uropodia at the trailing edge, shown by arrowhead). Hec1-NSP cells did not form podia.
NSPZ noneside population; SPZ side population.
68 K. KatoDNA probe, which hybridizes to the centromere of human
chromosome X, and the FITC-labeled DNA probe, which
hybridizes to mouse pan-centromeric chromosome. We
analyzed the signal numbers in three independent regions of
tumor and stromal tissues. Only red human signals wereFigure 7. Tumorigenicity was enhanced in Hec1-SP cells. (A) Sid
inoculated into the subcutaneous tissues of nude mice. (a, b) Ther
compared with that from NSP cells, although it was masked by large
mean standard error of the mean from three independent expe
tumor weight after 12 weeks of inoculation is shown as the m
experimentsdy-axis: tumor weight (g). SP: 1.72 0.54 g and NSP: 0
a-smooth muscle actin, and collagen III were analyzed by immunoh
tumor were stained with vimentin. Stroma-like cells in the SP tumo
vimentin, but the level of expression was less than that in the SP
tumor (magnification: 20 and 50, scale barZ 100 mm; 100, s
NSPZ noneside population; a-SMAZ a-smooth muscle actin; SPZdetected in the area of tumor tissues without ECM. Both red
human signals and green mouse signals were observed in the
area of stroma-like cells with enriched ECM. The ratio of
cells with red signals was significantly more than that of
cells with green signals in stroma-like tissues. These resultse population (SP) cells or noneside population (NSP) cells were
e was a trend toward an increased size of tumor from SP cells
variation between experiments. The tumor size is shown as the
riments. (b) y-axis: tumor size, lengthwidth (cm2). (c) The
ean standard error of the mean from three independent
.18 0.10 g (pZ 0.049). (B) The expression levels of vimentin,
istochemistry. Both tumor cells and stroma-like cells in the SP
r expressed a-SMA. Tumor cells in the NSP tumor also expressed
tumors. a-SMA and collagen III were not expressed in the NSP
cale barZ 50 mm). *pZ 0.045, **pZ 0.056, and ***pZ 0.074.
side population.
Figure 8. Most of the stromal-like cells were derived from the inoculated Hec1-SP cells. Fluorescence in situ hybridization (FISH)
assay was performed on Hec1-SP tumor tissues using the spectrum orange-labelled CEP X (a satellite) DNA probe, which hybridizes
to the centromere of human chromosome X and the FITC-labeled DNA probe, which hybridizes to mouse pan-centromeric chro-
mosome. In the area of tumor cells without ECM, only red signals (human chromosome) were detected. Both red signals and green
signals (mouse chromosome) were detected in the area of stroma-like cells with enriched ECM. The ratio of cells with red signals
was significantly more than that of cells with green signals (red: 76  4%, green 24  4% from three different regions of tumor cells
or stroma-like cells with enriched ECM). The hematoxylin and eosin (HE) panel shows HE staining of tumor cells and stroma-like
cells.
Figure 9. Side population cells differentiated into a-smooth muscle action (a-SMA)-expressing cells. 1105 Hec1-SP or Hec1-NSP
cells were cultured in Matrigel with a mesenchymal stem cell maintenance medium (MF-medium)(A, C), a standard growth medium
(DMEM containing 10% FCS)(B, D). After 8 weeks, the level of a-SMA expression was analyzed in each Matrigel sample. SP cells
cultured with either the standard growth medium (DMEM containing 10% FCS) expressed a-SMA. Hec1-NSP cells did not express
a-SMA in any culture condition. NSP Z noneside population; SP Z side population.
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derived from the inoculated human Hec1-SP cells (Fig. 8).
To further demonstrate the mesenchymal develop-
mental potential of SP cells in vitro, Hec1-SP or NSP cells
were seeded into Matrigel (BD Bioscience, Bedford, MA,
USA) and incubated with either a mesenchymal stem cell
maintenance medium (MF medium) or Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum
(FCS). After 8 weeks, the level of a-SMA expression was
analyzed in each Matrigel sample. The SP cells were
cultured with DMEM containing 10% FCS, which implied that
SP cells differentiated to the smooth muscle cell lineage.
The SP cells incubated with MF medium and the Hec1-NSP
cells in MF medium, and DMEM failed to express a-SMA
protein. These results suggest that SP cells have the
potential to develop a-SMA-expressing cells in a differenti-
ation medium (Fig. 9).
In this study, we demonstrated that an SP subpopulation
is present in cultures of human EC cells. The biological
characteristics of SP cells were distinct from those of NSP
cells. SP cells showed the following: (1) a reduction in the
expression levels of differentiation markers (CD9 and
CD13); (2) long-term proliferating capacity of the cell
culture; (3) self-renewal capacity in vitro; (4) enhance-
ment of migration and lamellipodia and uropodia forma-
tion; (5) enhanced tumorigenicity; and (6) bipotent
developmental potential (tumor and stroma-like cells).
The association of epithelial-mesenchymal transition with
the phenotype of migration enhancement and mesen-
chymal cell lineage differentiation in EC SP cells is
currently under investigation.
In conclusion, recent evidence demonstrates the presence
of stem-like cells in both normal endometrium and EC.
Endometrial stem-like cells have a multilineage develop-
mental potential. Theymay beapplicable to the regeneration
of not only injured endometrium but also of other tissues.
EC stem-like cells show enhanced tumorigenicity and
migration. Development of target therapy to EC stem cells
seems to contribute to the improvement of the prognosis
for patients with EC.
Acknowledgments
This work was supported by grants-in-aid 20659259,
22659302, and 22591869, from the Ministry of Education,
Culture, Sports, Science and Technology, Japan, and the
Environment Technology Development Fund of the Ministry
of the Environment, Japan.
References
[1] Bjerknes M, Cheng H. Clonal analysis of mouse intestinal
epithelial progenitors. Gastroenterology 1999;116:7e14.
[2] Alonso L, Fuchs E. Stem cells of the skin epithelium. Proc Natl
Acad Sci U S A 2003;100(Suppl. 1):11830e5.
[3] Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells.
Gene Ther 2002;9:642e7.
[4] Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S,
Friedman J, et al. Mouse hematopoietic stem cells. Blood
1991;78:1395e402.
[5] Morrison SJ, White PM, Zock C, Anderson DJ. Prospective
identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells.
Cell 1999;96:737e49.
[6] Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV,
et al. Direct isolation of human central nervous system stem
cells. Proc Natl Acad Sci U S A 2000;97:14720e5.
[7] Thomas T, Voss AK, Bartlett PF. Purification of a pluripotent
neural stem cell from the adult mouse brain. Nature 2001;412:
736e9.
[8] Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells,
cancer, and cancer stem cells. Nature 2001;414:105e11.
[9] Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived
stem cells. Blood 2003;102:3483e93.
[10] Goodell MA. Stem-cell “plasticity”: befuddled by the muddle.
Curr Opin Hematol 2003;10:208e13.
[11] Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isola-
tion and functional properties of murine hematopoietic stem
cells that are replicating in vivo. J Exp Med 1996;183:1797e806.
[12] Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath H,
Sorrentino BP. The ABC transporter Bcrp1/ABCG2 is expressed
in a wide variety of stem cells and is a molecular determinant
of the side population phenotype. Nat Med 2001;7:1028e34.
[13] Kondo T, Setoguchi T, Taga T. Persistence of a small subpop-
ulation of cancer stem-like cells in the C6 glioma cell line.
Proc Natl Acad Sci U S A 2004;101:781e6.
[14] Gargett CE. Review article: stem cells in human reproduction.
Reprod Sci 2007;14:405e24.
[15] Chan RW, Schwab KE, Gargett CE. Clonogenicity of human
endometrial epithelial and stromal cells. Biol Reprod 2004;70:
1738e50.
[16] Kato K, Yoshimoto M, Kato K, Adachi S, Yamayoshi A, Arima T,
et al. Characterization of side population cells in human
normal endometrium. Hum Reprod 2007;22:1214e23.
[17] Tsuji S, Yoshimoto M, Takahashi K, Noda Y, Nakahata T,
Heike T. Side population cells contribute to the genesis of
human endometrium. Fertil Steril 2008;90:1528e37.
[18] Masuda H, Matsuzaki Y, Hiratsu E, Ono M, Nagashima T,
Kajitani T, et al. Stem cell-like properties of the endometrial
side population: implication in endometrial regeneration.
PLoS One 2010;5:e10387.
[19] Hu FF, Xu J, Cui YG, Qian XQ, Mao YD, Liao LM, et al. Isolation
and characterization of side population cells in the post-
partum murine endometrium. Reprod Sci 2010;17:629e42.
[20] Cerrello I, Gil-Sanchis C, Mas A, Delgado-Rosas F, Martinez-
Conejero JA, Galan A, et al. Human endometrial side pop-
ulation cells exhibit genotypic, phenotypic and functional
features of somatic stem cells. PLoS One 2010;5:e10964.
[21] Schwab KE, Gargett CE. Co-expression of two perivascular cell
markers isolates mesenchymal stem-like cells from human
endometrium. Hum Reprod 2007;22:2903e11.
[22] Gotte M, Wolf M, Staebler A, Buchweitz O, Kelsch R,
Schuring AN, et al. Increased expression of the adult stem cell
marker Musashi-1 in endometriosis and endometrial carci-
noma. J Pathol 2008;215:317e29.
[23] Bonnet D, Dick JE. Human acute myeloid leukemia is organized
as a hierarchy that originates from a primitive hematopoietic
cell. Nat Med 1997;3:730e7.
[24] Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-
Cortes J, et al. A cell initiating human acute myeloid
leukaemia after transplantation into SCID mice. Nature 1994;
367:645e8.
[25] AI-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ,
Clarke MF. Prospective identification of tumorigenic breast
cancer cells. Proc Natl Acad Sci U S A 2003;100:3983e8.
[26] Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J,
et al. Identification of a cancer stem cell in human brain
tumors. Cancer Res 2003;63:5821e8.
[27] Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of
primitive human hematopoietic cells capable of repopulating
Characteristics of endometrial cancer side population cells 71immune-deficient mice. Proc Natl Acad Sci U S A 1997;94:
5320e5.
[28] Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-
Pinilla SM, Villa S, et al. Genetic profiling of epithelial cells
expressing E-cadherin repressors reveals a distinct role for
Snail, Slug, and E47 factors in epithelial-mesenchymal tran-
sition. Cancer Res 2006;66:9543e56.
[29] Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. The
PTEN tumor suppressor inhibits telomerase activity in endo-
metrial cancer cells by decreasing hTERT mRNA levels.
Gynecol Oncol 2006;101:305e10.
[30] Rossi DJ, Weissman IL. PTEN, tumorigenesis, and stem cell
self-renewal. Cell 2006;125:229e31.
[31] Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E,
Scadden DT, et al. Functional analyses of the cancer stemcell-like properties of human endometrial tumor initiating
cells. Cell Cycle 2008;7:242e9.
[32] Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR,
Gargett CE. Evidence for cancer stem cells in human endo-
metrial carcinoma. Cancer Res 2009;69:8241e8.
[33] Gotte M, Greve B, Kelsch R, Muller-Uthoff H, Weiss K,
Masouleh BK, et al. The adult stem cell marker Musashi-1
modulates endometrial carcinoma cell cycle progression and
apoptosis via notch-1 and p21 (WAF1/CIP1). Int J Cancer,
doi:10.10021ijc.25856.
[34] Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T,
Yamaguchi S, et al. Endometrial cancer side population cells
show prominent migration and have a potential to differen-
tiate into the mesenchymal cell lineage. Am J Pathol 2010;
176:381e92.
